Trends in treatments for prostate cancer in the United States, 2010-2015.
Jianwei Wang, Harry Hua‐Xiang Xia, Yuanyuan Zhang, Lanjing Zhang
Abstract
<0.01). In conclusion, ASUR and ASUP for prostate cancer treatments, including NOS treatment, had changed during 2010-2015. Their trends appeared to differ by cancer risk-group, age, race/ethnicity, Gleason score and socioeconomic factors. Future studies are warranted to understand the impacts of upward trends in ASUP of NOS treatments and AS/WW on patient survival and prostate cancer mortality.
Topics & Concepts
Prostate cancerMedicineProstatectomyWatchful waitingCancerEpidemiologyResidenceProstateRadiation therapyInternal medicineCancer registryOncologyDemographyGynecologySociologyProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchGlobal Cancer Incidence and Screening